ACTRN12622001386729
Recruiting
未知
Clinical Trial assessing the safety and feasibility of performing robotic-assisted multivisceral complete soft tissue extended resections (CSTER) in adults with advanced or recurrent abdominal tumours.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sydney Local Health District
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adults aged 18 years or older
- •2\. Cognitively able to give written informed consent for participation
- •3\. Patients who have one of the following pathologies, and who are deemed by the Pelvic Exenteration MDT as being suitable for robotic multivisceral complete soft tissue extended resection:
- •a. Primary pelvic malignancy
- •b. Locally recurrent cancer of the central compartment
- •c. Colovesical, rectourethral or rectovaginal fistulae
- •4\. Elective procedures
Exclusion Criteria
- •1\. Patients unable or unwilling to undergo pre and post\-operative evaluation as per the study protocol
- •2\. Patient and/or disease factors precluding robotic assisted multivisceral soft tissue extended resections such as:
- •a. Previous multiple complex abdominal surgeries
- •b. Bony resection required as part of the extended resection
- •c. Vascular reconstruction required as part of the extended resection
- •d. Other factors as determined by the treating surgeon or Pelvic Exenteration MDT
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Clinical trial to evaluate the safety and feasibility of online adaptive radiotherapy using cone-beam CT for pancreatic cancerpancreatic cancerC535836JPRN-jRCT1051230087Mizowaki Takashi10
Completed
Phase 1
Clinical trial to investigate safety and feasibility of Roux-Y with aboral pouch reconstruction after laparoscopically assisted total gastrectomygastric cancerJPRN-UMIN000005120Tohoku University Hospital Division of Gastrointestinal Surgery10
Active, not recruiting
Not Applicable
Clinical trial evaluating medical-grade polycaprolactone-PCL breast scaffold implantation with autologous fat grafting for breast implant revision and congenital defect correction surgeryBreast implant revisionCongenital defect correctionSurgery - Surgical techniquesACTRN12622000147785BellaSeno Pty Ltd19
Active, not recruiting
Not Applicable
Clinical trial evaluating medical-grade polycaprolactone- PCL Pectus scaffold implantation with autologous fat grafting for pectus excavatum camouflagePectus excavatumSoft tissue defectSurgery - Surgical techniquesMusculoskeletal - Other muscular and skeletal disordersACTRN12621000798864BellaSeno Pty Ltd7
Not yet recruiting
Phase 2
Clinical Trial of Siddha Medicine Nandhi Mezhugu in the Treatment of Breast CancerHealth Condition 1: C50- Malignant neoplasm of breastHealth Condition 2: C500- Malignant neoplasm of nipple and areolaHealth Condition 3: C500- Malignant neoplasm of nipple and areolaCTRI/2021/10/037630Central Council for Research in Siddha Arumbakkam Chennai